These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 23731)

  • 1. A serotonergic component of neuroleptic receptors.
    Leysen JE; Laduron PM
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):337-9. PubMed ID: 23731
    [No Abstract]   [Full Text] [Related]  

  • 2. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex.
    Arbilla S; Briley MS; Dubocovich ML; Langer SZ
    Life Sci; 1978 Oct; 23(17-18):1775-80. PubMed ID: 31532
    [No Abstract]   [Full Text] [Related]  

  • 4. Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex.
    Leysen JE; Gommeren W
    Life Sci; 1978 Aug; 23(5):447-52. PubMed ID: 29187
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas.
    Leysen JE; Gommeren W; Laduron PM
    Biochem Pharmacol; 1979; 28(3):447-8. PubMed ID: 34403
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differences in the efficiency of their interaction with membrane receptors of the dialkylaminoalkyl and dialkylaminoacyl derivatives of phenothiazine].
    Savel'eva MV; Ratner EI; Baldenko GN; Kaverina NV
    Biull Eksp Biol Med; 1990 Mar; 109(3):266-8. PubMed ID: 1973058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.
    Leysen JE; Gommeren W; Laduron PM
    Biochem Pharmacol; 1978 Feb; 27(3):307-16. PubMed ID: 23126
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS; Goldman-Rakic PS
    J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats.
    Imperato A; Angelucci L
    Psychopharmacol Bull; 1989; 25(3):383-9. PubMed ID: 2576318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal infusion of amiloride increases rotations in 6-OHDA lesioned rats and "down-regulates" D2 receptors in the striatum and 5-HT2A receptors in the cortex.
    Jamrozik Z; De Yebenes JG; Troung DD; Cadet J
    Pol J Pharmacol; 1994; 46(5):417-22. PubMed ID: 7894528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
    Marshall AM; Mishra RK
    Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists.
    Mannoury la Cour C; Vidal S; Pasteau V; Cussac D; Millan MJ
    Neuropharmacology; 2007 Mar; 52(3):1003-14. PubMed ID: 17178132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors.
    Reitz AB; Baxter EW; Codd EE; Davis CB; Jordan AD; Maryanoff BE; Maryanoff CA; McDonnell ME; Powell ET; Renzi MJ; Schott MR; Scott MK; Shank RP; Vaught JL
    J Med Chem; 1998 Jun; 41(12):1997-2009. PubMed ID: 9622541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimuscarinic actions of neuroleptic drugs.
    Miller R; Hiley R
    Adv Neurol; 1975; 9():141-54. PubMed ID: 167564
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.
    Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ
    Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Participation of brain 5-HT1A serotonin receptors in regulating hereditary catalepsy].
    Popova NK; Kulikov AV; Avgustinovich DF; Vishnivetskaia GB; Kolpakov VG
    Biull Eksp Biol Med; 1994 Dec; 118(12):633-5. PubMed ID: 7703461
    [No Abstract]   [Full Text] [Related]  

  • 18. [The biochemical effects of a new antidepressive, metapramine (RP 19560) on activity of the dopaminergic and cholinergic systems of the rat striatum].
    Boireau A; Garret C; Blanchard JC
    J Pharmacol; 1986; 17(1):75-84. PubMed ID: 2872367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]Sulpiride, a ligand for neuroleptic receptors.
    Freedman SB; Poat JA; Woodruff GN
    Neuropharmacology; 1981 Dec; 20(12B):1323-6. PubMed ID: 6119644
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.